| 3601 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
44 |
| 3602 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3603 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3604 |
Bone Marrow |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3605 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3606 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency Syndrome With Hyper-Igm |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3607 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
4 |
| 3608 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3609 |
Bone Marrow |
Allogeneic |
Hurler Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3610 |
Bone Marrow |
Allogeneic |
Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3611 |
Bone Marrow |
Allogeneic |
Inherited Immune System Disorder |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3612 |
Bone Marrow |
Allogeneic |
Ipex- Other Immune |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3613 |
Bone Marrow |
Allogeneic |
Leukemia Lymphoblastic Acuta |
Hematology |
2021 |
Standard Therapy |
Poland |
6 |
| 3614 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3615 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3616 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
2 |
| 3617 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
30 |
| 3618 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
67 |
| 3619 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3620 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3621 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3622 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3623 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
14 |
| 3624 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3625 |
Bone Marrow |
Allogeneic |
Osteopetrosis |
Hematology |
2021 |
Standard Therapy |
Poland |
7 |
| 3626 |
Bone Marrow |
Allogeneic |
Other Leukemia Specify |
Hematology |
2021 |
Standard Therapy |
Poland |
35 |
| 3627 |
Bone Marrow |
Allogeneic |
Other Myelofibrosis |
Hematology |
2021 |
Standard Therapy |
Poland |
72 |
| 3628 |
Bone Marrow |
Allogeneic |
Refractory Cytopenia |
Hematology |
2021 |
Standard Therapy |
Poland |
7 |
| 3629 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3630 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3631 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
12 |
| 3632 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3633 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3634 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
12 |
| 3635 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3636 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3637 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3638 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
9 months |
| 3639 |
Apheresis |
Allogeneic |
Acute Biphenotypic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3640 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
17 |
| 3641 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3642 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3643 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3644 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3645 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
27 |
| 3646 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3647 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
51 |
| 3648 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
65 |
| 3649 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3650 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3651 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3652 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3653 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3654 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3655 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3656 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3657 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3658 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3659 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3660 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3661 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3662 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3663 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
19 |
| 3664 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3665 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3666 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3667 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
29 |
| 3668 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
8 |
| 3669 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3670 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3671 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
6 |
| 3672 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3673 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3674 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3675 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3676 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia – Relapse |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3677 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3678 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3679 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3680 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3681 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3682 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3683 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3684 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
48 |
| 3685 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3686 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3687 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
50 |
| 3688 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3689 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3690 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
46 |
| 3691 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3692 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3693 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
45 |
| 3694 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3695 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3696 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3697 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3698 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
37 |
| 3699 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
21 |
| 3700 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
60 |